Found: 11
Select item for more details and to access through your institution.
Severe peripheral arterial disease during nilotinib therapy.
- Published in:
- 2011
- By:
- Publication type:
- letter
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1154377
- By:
- Publication type:
- Article
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 9, p. 1823, doi. 10.1038/leu.2015.152
- By:
- Publication type:
- Article
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Multiple skin tumors in long-term treatment with hydroxyurea.
- Published in:
- European Journal of Haematology, 1992, v. 48, n. 2, p. 121, doi. 10.1111/j.1600-0609.1992.tb00580.x
- By:
- Publication type:
- Article
A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes.
- Published in:
- 2000
- By:
- Publication type:
- journal article
CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemia.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the "RAMP" Italian multicenter prospective study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 6, p. 1931, doi. 10.1007/s00277-024-05704-0
- By:
- Publication type:
- Article
Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article